Status:
COMPLETED
Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery
Lead Sponsor:
Chaudhry Pervaiz Elahi Institute of Cardiology
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20-20 years
Phase:
NA
Brief Summary
Propofol and midazolam are used frequently as sedating agents among patients who undergo coronary artery bypass graft surgery but no study in Pakistan has been done to compare their effectiveness aimi...
Detailed Description
Propofol is an intra lipid and alkali phenol chemically it is unrelated to sedative agents or anaesthetic. Midazolam is a banzodiazepen. Most of its properties are similar to diazepam. It is a common ...
Eligibility Criteria
Inclusion
- Patients of American Society of Anesthesiologists (ASA) III who were selected for coronary artery bypass graft surgery.
Exclusion
- History of any psychiatric disease.
- Using antidepressants
- Alcohol abusers
- Obese
- Pregnant women
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05290324
Start Date
February 1 2019
End Date
February 1 2020
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ch. Pervaiz Elahi Institute of Cardiology
Multan, Punjab Province, Pakistan, 59341